Nosinform, or sacubatril valsartan sodium tablets, belongs to the latest type of drugs for the treatment of heart failure, mainly used for patients with chronic heart failure with reduced ejection fraction, which can improve the clinical symptoms and long-term prognosis of patients with heart failure, reduce the risk of cardiovascular death and hospitalization for heart failure, especially for patients with hypertension combined with heart failure. This drug can also be used in combination with other drugs for the treatment of heart failure, taking effective long-term medication, can not be discontinued, such as the need to adjust or discontinue the drug, you need to consult a cardiovascular specialist, but this drug can not be used with ACEI drugs. During the period of taking the drug, it is necessary to monitor the blood pressure, blood potassium, kidney function and other indicators, it is recommended that the treatment of heart failure at the same time, you need to pay attention to salt restriction, water restriction, more rest, avoid emotional excitement and fatigue and so on.